A demonstration of analytical similarity comparing a proposed biosimilar pegfilgrastim and reference pegfilgrastim

Abstract

These studies provide robust evidence supporting the structural and functional similarity between Apobiologix pegfilgrastim and the US-licensed reference pegfilgrastim, and hence their biosimilarity.